CMV prophylaxis: What is valid in 2002?

Uwe Heemann; Rene R. Wenzel

doi:10.1093/ndt/17.4.556

CMV prophylaxis: What is valid in 2002?

Uwe Heemann, Rene R. Wenzel

University Hospital of Essen

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

In summary, CMV should be considered in all cases of diarrhoea, creatinine increase, and/or leucopenia. In these cases and/or on a regular basis early markers for CMV should be tested and pre-emptive therapy initiated if tests give a positive result for as long as tests are positive.

Original language	English
Pages (from-to)	556-559
Number of pages	4
Journal	Nephrology Dialysis Transplantation
Volume	17
Issue number	4
DOIs	https://doi.org/10.1093/ndt/17.4.556
State	Published - 2002
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ndt/17.4.556

Cite this

@article{501aacc9dacc40c298b1b85ca6f6b038,

title = "CMV prophylaxis: What is valid in 2002?",

abstract = "In summary, CMV should be considered in all cases of diarrhoea, creatinine increase, and/or leucopenia. In these cases and/or on a regular basis early markers for CMV should be tested and pre-emptive therapy initiated if tests give a positive result for as long as tests are positive.",

author = "Uwe Heemann and Wenzel, {Rene R.}",

year = "2002",

doi = "10.1093/ndt/17.4.556",

language = "English",

volume = "17",

pages = "556--559",

journal = "Nephrology Dialysis Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - CMV prophylaxis

T2 - What is valid in 2002?

AU - Heemann, Uwe

AU - Wenzel, Rene R.

PY - 2002

Y1 - 2002

N2 - In summary, CMV should be considered in all cases of diarrhoea, creatinine increase, and/or leucopenia. In these cases and/or on a regular basis early markers for CMV should be tested and pre-emptive therapy initiated if tests give a positive result for as long as tests are positive.

AB - In summary, CMV should be considered in all cases of diarrhoea, creatinine increase, and/or leucopenia. In these cases and/or on a regular basis early markers for CMV should be tested and pre-emptive therapy initiated if tests give a positive result for as long as tests are positive.

UR - http://www.scopus.com/inward/record.url?scp=0036222479&partnerID=8YFLogxK

U2 - 10.1093/ndt/17.4.556

DO - 10.1093/ndt/17.4.556

M3 - Article

C2 - 11917045

AN - SCOPUS:0036222479

SN - 0931-0509

VL - 17

SP - 556

EP - 559

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

IS - 4

ER -

CMV prophylaxis: What is valid in 2002?

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this